Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options
- 1 August 1996
- journal article
- review article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 33  (4) , 235-248
- https://doi.org/10.1016/s0195-6701(96)90010-9
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDSNew England Journal of Medicine, 1995
- Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled TrialAnnals of Internal Medicine, 1995
- Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adultsAntimicrobial Agents and Chemotherapy, 1995
- (S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine (Cidofovir): Results of a Phase I/II Study of a Novel Antiviral Nucleotide AnalogueThe Journal of Infectious Diseases, 1995
- FoscarnetDrugs, 1994
- Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteersClinical Pharmacology & Therapeutics, 1993
- Acyclovir: A Decade LaterNew England Journal of Medicine, 1992
- Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and diseaseBlood, 1991
- GanciclovirDrugs, 1990
- Acyclovir-Resistant Herpes Simplex Virus Infections in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989